1. Home
  2. FEIM vs DERM Comparison

FEIM vs DERM Comparison

Compare FEIM & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEIM
  • DERM
  • Stock Information
  • Founded
  • FEIM 1961
  • DERM 2014
  • Country
  • FEIM United States
  • DERM United States
  • Employees
  • FEIM N/A
  • DERM N/A
  • Industry
  • FEIM Electrical Products
  • DERM Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEIM Industrials
  • DERM Health Care
  • Exchange
  • FEIM Nasdaq
  • DERM Nasdaq
  • Market Cap
  • FEIM 119.5M
  • DERM 107.0M
  • IPO Year
  • FEIM N/A
  • DERM 2021
  • Fundamental
  • Price
  • FEIM $13.14
  • DERM $5.20
  • Analyst Decision
  • FEIM
  • DERM Strong Buy
  • Analyst Count
  • FEIM 0
  • DERM 3
  • Target Price
  • FEIM N/A
  • DERM $9.50
  • AVG Volume (30 Days)
  • FEIM 25.4K
  • DERM 145.7K
  • Earning Date
  • FEIM 12-10-2024
  • DERM 11-12-2024
  • Dividend Yield
  • FEIM 7.56%
  • DERM N/A
  • EPS Growth
  • FEIM N/A
  • DERM N/A
  • EPS
  • FEIM 0.62
  • DERM N/A
  • Revenue
  • FEIM $57,943,000.00
  • DERM $57,771,000.00
  • Revenue This Year
  • FEIM N/A
  • DERM N/A
  • Revenue Next Year
  • FEIM N/A
  • DERM $37.38
  • P/E Ratio
  • FEIM $21.11
  • DERM N/A
  • Revenue Growth
  • FEIM 28.82
  • DERM N/A
  • 52 Week Low
  • FEIM $8.62
  • DERM $2.85
  • 52 Week High
  • FEIM $14.50
  • DERM $8.11
  • Technical
  • Relative Strength Index (RSI)
  • FEIM 60.80
  • DERM 43.96
  • Support Level
  • FEIM $12.72
  • DERM $5.00
  • Resistance Level
  • FEIM $13.25
  • DERM $5.60
  • Average True Range (ATR)
  • FEIM 0.40
  • DERM 0.45
  • MACD
  • FEIM 0.02
  • DERM -0.04
  • Stochastic Oscillator
  • FEIM 72.83
  • DERM 14.98

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Share on Social Networks: